@khoslaventures.bsky.social
June 19, 2025 at 12:02 AM
ICYMI - Kanu Gulati at @techcrunch.com Sessions on what to look for in early stage founders
“I want to understand what can be demonstrable in the next three years vs. what’s still hype."
techcrunch.com/video/cut-th...
“I want to understand what can be demonstrable in the next three years vs. what’s still hype."
techcrunch.com/video/cut-th...
June 13, 2025 at 4:45 PM
ICYMI - Kanu Gulati at @techcrunch.com Sessions on what to look for in early stage founders
“I want to understand what can be demonstrable in the next three years vs. what’s still hype."
techcrunch.com/video/cut-th...
“I want to understand what can be demonstrable in the next three years vs. what’s still hype."
techcrunch.com/video/cut-th...
Thrilled to see KV-backed innovation shaping the future on this year’s CNBC #Disruptor50 list. Huge congrats to all the teams! 🥳
www.cnbc.com/2025/06/10/2...
www.cnbc.com/2025/06/10/2...
June 11, 2025 at 4:45 PM
Thrilled to see KV-backed innovation shaping the future on this year’s CNBC #Disruptor50 list. Huge congrats to all the teams! 🥳
www.cnbc.com/2025/06/10/2...
www.cnbc.com/2025/06/10/2...
KV Summit 2025… racing to utopia!
June 6, 2025 at 5:41 PM
KV Summit 2025… racing to utopia!
20 years of building and beyond
June 5, 2025 at 6:08 PM
20 years of building and beyond
Welcome to the KV portfolio, ClickHouse! 🎉 Powering lightning-fast, real-time analytics for the AI era.
More here 👇
www.bloomberg.com/news/article...
More here 👇
www.bloomberg.com/news/article...
May 29, 2025 at 5:19 PM
Welcome to the KV portfolio, ClickHouse! 🎉 Powering lightning-fast, real-time analytics for the AI era.
More here 👇
www.bloomberg.com/news/article...
More here 👇
www.bloomberg.com/news/article...
Traditional cell therapies are expensive, slow to develop, and difficult to scale.
Somite AI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy.
Somite AI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy.
May 13, 2025 at 7:32 PM
Traditional cell therapies are expensive, slow to develop, and difficult to scale.
Somite AI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy.
Somite AI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy.
"Behind every great company, there was a prescient early investor who planted the seed that helped it grow into a redwood.
For Facebook, that investor was Peter Thiel. For DoorDash and Opendoor, it was Keith Rabois."
For Facebook, that investor was Peter Thiel. For DoorDash and Opendoor, it was Keith Rabois."
May 12, 2025 at 11:14 PM
"Behind every great company, there was a prescient early investor who planted the seed that helped it grow into a redwood.
For Facebook, that investor was Peter Thiel. For DoorDash and Opendoor, it was Keith Rabois."
For Facebook, that investor was Peter Thiel. For DoorDash and Opendoor, it was Keith Rabois."
May 8, 2025 at 12:05 AM
Congrats to Alice Brooks on @SFBusinessTimes 40 under 40!
"I get to work with entrepreneurs solving the world's toughest problems: unlocking limitless fusion energy, growing more scalable sources of protein, creating high-performing circular materials and chemicals and more."
"I get to work with entrepreneurs solving the world's toughest problems: unlocking limitless fusion energy, growing more scalable sources of protein, creating high-performing circular materials and chemicals and more."
April 25, 2025 at 8:19 PM
Congrats to Alice Brooks on @SFBusinessTimes 40 under 40!
"I get to work with entrepreneurs solving the world's toughest problems: unlocking limitless fusion energy, growing more scalable sources of protein, creating high-performing circular materials and chemicals and more."
"I get to work with entrepreneurs solving the world's toughest problems: unlocking limitless fusion energy, growing more scalable sources of protein, creating high-performing circular materials and chemicals and more."
Sci-fi becomes reality: Almost 10 yrs ago we backed eGenesis to solve the global organ shortage by genetically modifying pig organs for humans.
Today they announced a second patient received one of their pig kidneys.
Today they announced a second patient received one of their pig kidneys.
February 8, 2025 at 12:24 AM
Sci-fi becomes reality: Almost 10 yrs ago we backed eGenesis to solve the global organ shortage by genetically modifying pig organs for humans.
Today they announced a second patient received one of their pig kidneys.
Today they announced a second patient received one of their pig kidneys.
Bringing healthcare changemakers together!🌟 Our annual JPM reception yesterday brought together experts, innovators, and visionaries driving the future of healthcare.
January 16, 2025 at 11:33 PM
Bringing healthcare changemakers together!🌟 Our annual JPM reception yesterday brought together experts, innovators, and visionaries driving the future of healthcare.